US Patent Issued to KING FAISAL UNIVERSITY on April 8 for "7H-pyrido[4',3':4,5pyrrolo[2,3-c[1,7naphthyridine compounds as CK2 inhibitors" (Saudi Arabia Inventors)

ALEXANDRIA, Va., April 9 -- United States Patent no. 12,269,826, issued on April 8, was assigned to KING FAISAL UNIVERSITY (Al-Ahsa, Saudi Arabia).

"7H-pyrido[4',3':4,5pyrrolo[2,3-c[1,7naphthyridine compounds as CK2 inhibitors" was invented by Michelyne Haroun (Al-Ahsa, Saudi Arabia) and Christophe Tratrat (Al-Ahsa, Saudi Arabia).

According to the abstract* released by the U.S. Patent & Trademark Office: "Novel 7H-pyrido[4',3':4,5]pyrrolo[2,3-c][1,7]naphthyridine compounds, a method of synthesizing said compounds, a pharmaceutical composition comprising said compounds and a suitable carrier, and a method of using the compounds. The 7H-pyrido[4',3':4,5]pyrrolo[2,3-c][1,7]naphthyridine compounds, identified as CK2 inhibitors, are useful as ...